Eye-Health Supplements

What qualifies for the Eye Health directory?

This page compares current finished products explicitly positioned for eye, macular or ocular nutrition. The current market includes AREDS2 formulas, focused carotenoid products and broader multinutrient formulas, so they should not share one undifferentiated ranking.

The verified set includes two Life Extension MacuGuard formulas, PreserVision AREDS 2 MiniGels, Ocuvite Adult 50+, NOW Lutein & Zeaxanthin and NOW Ocu Support.

AREDS2, carotenoid and multinutrient formulas are different classes

PreserVision AREDS 2 MiniGels belongs to the AREDS2 formula class. NOW Lutein & Zeaxanthin is a focused carotenoid product. MacuGuard formulas combine carotenoids with saffron and, in one version, astaxanthin. Ocuvite Adult 50+ and NOW Ocu Support are broader eye-health multinutrient products.

This creates the first information-gain layer: eye supplements should be classified by formula type before nutrient amounts are compared.

Lutein and zeaxanthin need direct amount fields

NOW Lutein & Zeaxanthin currently provides 25 mg lutein plus 5 mg zeaxanthin per softgel. MacuGuard Ocular Support with Saffron currently provides 10 mg lutein plus 4 mg combined meso-zeaxanthin/zeaxanthin within its blend.

MenPS should preserve exact label amounts where current official sources disclose them and avoid assuming that higher carotenoid amounts automatically mean better clinical outcomes.

Saffron and astaxanthin create a separate MacuGuard branch

The standard MacuGuard with Saffron currently provides 20 mg saffron extract per softgel. Life Extension's advanced MacuGuard formula adds astaxanthin to the carotenoid/saffron architecture. These products should be compared as different finished formulations rather than treated as duplicate brand entries.

AREDS2 status should be an explicit field

PreserVision currently identifies its MiniGels as the AREDS2 nutrient formula and directs two soft gels daily with food. Because AREDS2 is a specific formula concept, MenPS should record AREDS2 status separately rather than merge it with generic “eye vitamin” positioning.

Ocuvite Adult 50+ is an age-positioned multinutrient subtype

Ocuvite currently lists Adult 50+ with eight eye-health nutrients: lutein, zeaxanthin, omega-3s, zinc, copper and vitamins C, D and E. The current site specifies 30 mcg vitamin D. This is a broader architecture than a focused lutein/zeaxanthin softgel.

Availability should remain separate from current product identity

NOW Ocu Support remains a current product page but is presently out of stock. NOW Lutein & Zeaxanthin has mixed stock status by bottle size. MenPS should therefore track current identity and current availability separately.

Recommended Eye-Health data model

The core fields should be formula class, AREDS2 status, lutein amount, zeaxanthin/meso-zeaxanthin amount, saffron, astaxanthin, vitamin/mineral coverage, omega-3 inclusion, serving format, availability and source-check date.

Eye-health positioning should not become disease-treatment guidance

Manufacturer pages can verify formula composition and commercial positioning. MenPS should not imply that a general eye supplement treats macular degeneration, cataracts or another eye disease. Products based on AREDS2 should be described accurately without turning the catalog into individual medical advice.

Current-source verification

All six current rows were freshly checked during the September audit. Current label data supports direct carotenoid comparison, while availability flags are preserved separately.

Useful follow-up questions

Is every eye supplement an AREDS2 formula?

No. The category also includes focused carotenoid and broader multinutrient products.

Why list NOW Ocu Support if it is out of stock?

Because current product identity and live inventory availability are separate facts.

Does more lutein automatically mean a better eye supplement?

No. Lutein amount is a catalog attribute, not a universal efficacy ranking.

Ocuvite Adult 50+ is explicitly age-positioned, while other products are organized around AREDS2 or carotenoid composition. Age targeting should therefore be a separate catalog field rather than used as a substitute for ingredient-level comparison.

Age positioning should be recorded separately from formula type

Primary product sources used for this snapshot

Current product identity, composition and positioning were checked against official manufacturer sources. These support catalog facts and attributed positioning, not independent efficacy conclusions.

• Life Extension MacuGuard Ocular Support with Saffron - current product source
• Life Extension MacuGuard Ocular Support with Saffron & Astaxanthin - current product source
• PreserVision AREDS 2 Formula MiniGels - current product source
• Ocuvite Adult 50+ - current product source
• NOW Lutein & Zeaxanthin - current product source
• NOW Ocu Support - current product source

Serving format changes how eye formulas are used

The current set includes softgels, mini-gels and capsule formulas with different serving frequencies. PreserVision AREDS 2 MiniGels uses two soft gels daily with food, while MacuGuard with Saffron uses one softgel daily. NOW Lutein & Zeaxanthin also uses one softgel daily. MenPS should therefore keep serving format and daily serving burden visible beside nutrient amounts.

Broad eye formulas should expose nutrient classes instead of a single score

Ocuvite Adult 50+ includes carotenoids, omega-3s, zinc, copper and antioxidant vitamins, while NOW Ocu Support combines carotenoids with a broader antioxidant/nutrient system. Those products should be summarized by nutrient class and key disclosed amounts rather than reduced to a generic “comprehensive eye formula” label.